No-Spa Forte (Drotaverine Hydrochloride)

Drotaverine Hydrochloride, the active ingredient in No-Spa Forte, is an antispasmodic (phosphodiesterase inhibitor) presented as an oral tablet for oral use. It relaxes smooth muscle and is employed to alleviate abdominal pain, menstrual cramps, biliary and renal colic, and other spasm‑related conditions in adult patients.

GNH USA supplies No‑Spa Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand through reliable logistics and dedicated customer support.

Drotaverine Hydrochloride is used to relieve smooth‑muscle spasm in several gastrointestinal and genitourinary conditions. - Abdominal pain: reduces pain by relaxing intestinal smooth muscle. - Menstrual cramps (dysmenorrhea): alleviates uterine contractions and associated discomfort. - Biliary colic: eases gall‑bladder smooth‑muscle spasm, improving pain control. - Renal colic: relaxes ureteral smooth muscle to facilitate stone passage and reduce pain. - Gastro‑genitourinary spasm: diminishes spasms of the gastrointestinal or genitourinary tract, improving symptom relief.

Adverse reactions to Drotaverine Hydrochloride are generally mild but can include more serious events.

Common Side Effects: - Nausea: mild stomach upset. - Dizziness: transient light‑headedness. - Headache: mild to moderate intensity. - Dry mouth: reduced salivation. - Hypotension: slight drop in blood pressure.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Severe hypotension: marked blood pressure fall. - Cardiac arrhythmia: irregular heartbeat. - Hepatic dysfunction: elevated liver enzymes. - Anaphylaxis: life‑threatening systemic reaction.

When prescribing Drotaverine Hydrochloride, clinicians should observe the following precautions. - Pregnancy: use only if clearly needed, as safety data are limited. - Breastfeeding: caution advised; monitor infant for adverse effects. - Hepatic impairment: consider dose adjustment or close monitoring. - Renal impairment: use with caution; monitor renal function. - Concomitant antihypertensives: may enhance hypotensive effect. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Drotaverine Hydrochloride may interact with other medicines; notable interactions are grouped below.

Major Interactions (Avoid): - Nitrates: additive vasodilatory effect may cause severe hypotension. - Alpha‑blockers: combined use can lead to pronounced blood pressure reduction. - Other phosphodiesterase inhibitors: risk of excessive smooth‑muscle relaxation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance hypotensive response. - Anticholinergic drugs: potential for additive dry‑mouth or constipation. - CYP450 substrates: Drotaverine may affect metabolism of certain drugs, requiring monitoring.